These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 582150)

  • 1. Some developments with tumour markers [proceedings].
    Bagshawe KD
    Arzneimittelforschung; 1979; 29(2):355-6. PubMed ID: 582150
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour markers. A clinical review.
    Sandeman TF; Boyne P
    Aust Fam Physician; 1985 May; 14(5):420-6. PubMed ID: 4015544
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical usefulness of tumour markers.
    Lai LC; Cheong SK; Goh KL; Leong CF; Loh CS; Lopez JB; Nawawi H; Sivanesaratnam V; Subramaniam R;
    Malays J Pathol; 2003 Dec; 25(2):83-105. PubMed ID: 16196365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic tumor diagnosis].
    Schmolke B
    Z Lymphol; 1990 Dec; 14(2):58-61. PubMed ID: 2087871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in imaging and functional biomarker technology for the assessment and management of cancer patients.
    Hall NC; Zhang J; Povoski SP; Martin EW; Knopp MV
    Expert Rev Med Devices; 2009 Jul; 6(4):347-51. PubMed ID: 19572788
    [No Abstract]   [Full Text] [Related]  

  • 6. [Future prospects for the use of tumor markers].
    Grunicke H
    Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expecting the unexpected--the continued need for vigilance in tumour marker assays.
    Sturgeon C
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):247-8. PubMed ID: 16824272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glycosphingolipids as tumor markers].
    Lenícková L; Smíd F
    Cas Lek Cesk; 1997 Nov; 136(21):655-61. PubMed ID: 9490212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
    Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
    Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumour markers in clinical practice. Some general aspects.
    Kvinnsland S
    Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy. Tumour markers in clinical practice.
    Buckman R
    Br J Hosp Med; 1982 Jan; 27(1):9, 13-14, 17 passim. PubMed ID: 6174166
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development of immunoscintigraphy into a routine method].
    Pateisky N
    Wien Klin Wochenschr; 1990 Aug; 102(15):424-6. PubMed ID: 2205987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein chips and nanomaterials for application in tumor marker immunoassays.
    Chen H; Jiang C; Yu C; Zhang S; Liu B; Kong J
    Biosens Bioelectron; 2009 Aug; 24(12):3399-411. PubMed ID: 19398322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour markers: their use and misuse by clinicians.
    McGinley PJ; Kilpatrick ES
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):643-7. PubMed ID: 14629802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers--an update. Proceedings from the first meeting on tumour markers. Trondheim, 24-25 May 1991.
    Scand J Clin Lab Invest Suppl; 1991; 206():5-105. PubMed ID: 1947759
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumour markers in malignant diseases].
    Ottó S; Ferencz A
    Magy Onkol; 2004; 48(1):13-20. PubMed ID: 15105891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Tumour immunity - cellular and humoral responses during tumour growth.
    Baldwin RW; Embleton MJ; Price MR; Robins RA
    Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139105
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The MEM test in the diagnosis and prognosis of malignant disease.
    Pritchard JA
    Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 1276610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.